TREATMENT OF PARKINSONS DISEASE WITH AMANTADINE AND LEVODOPA - ONE-YEAR STUDY

被引：0
作者：
PARKES, JD
CURZON, G
KNOTT, PJ
TATTERSALL, R
BAXTER, RCH
KNILLJON.RP
MARSDEN, CD
VOLLUM, D
机构：
来源：
LANCET | 1971年 / 1卷 / 7709期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1083 / +
页数：1
相关论文
共 24 条
[1]  
ANSEL RD, 1970, L DOPA PARKINSONISM, P69
[2]   CEREBROSPINAL FLUID HOMOVANILLIC ACID CONCENTRATION IN PATIENTS WITH PARKINSONISM TREATED WITH L-DOPA [J].
CURZON, G ;
GODWINAU.RB ;
TOMLINSO.EB ;
KANTAMAN.BD .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1970, 33 (01) :1-&
[3]   USE OF AMANTADINE IN PARKINSONS DISEASE - RESULTS OF A DOUBLE-BLIND TRIAL [J].
DALLOS, V ;
HEATHFIELD, K ;
STONE, P ;
ALLEN, FAD .
BMJ-BRITISH MEDICAL JOURNAL, 1970, 4 (5726) :24-+
[4]  
DUVOISIN R, 1969, 3 S PARK DIS, P185
[5]  
GETZ R, 1970, South African Medical Journal, V44, P955
[6]  
GODWINAUSTEN RB, 1969, LANCET, V2, P165
[7]  
GODWINAUSTEN RB, IN PRESS
[8]   AMANTADINE-DOPAMINE INTERACTION - POSSIBLE MODE OF ACTION IN PARKINSONISM [J].
GRELAK, RP ;
CLARK, R ;
STUMP, JM ;
VERNIER, VG .
SCIENCE, 1970, 169 (3941) :203-+
[9]  
HUNTER KR, 1970, LANCET, V1, P1127
[10]   FLUORIMETRIC DETERMINATION OF 5-HYDROXYINDOLEACETIC ACID IN HUMAN URINE AND CEREBROSPINAL FLUID [J].
KORF, J ;
VALKENBU.T .
CLINICA CHIMICA ACTA, 1969, 26 (02) :301-&
123